Cargando…
Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement
Several randomized and observational studies have reported steady increase in cumulative incidence of late and very late ST (LST/VLST) following first-generation drug-eluting stents (DES: sirolimus-(SES) and paclitaxel-(PES)) up to 5 years. Pathologic studies have identified uncovered struts as the...
Autores principales: | Otsuka, Fumiyuki, Nakano, Masataka, Ladich, Elena, Kolodgie, Frank D., Virmani, Renu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512327/ https://www.ncbi.nlm.nih.gov/pubmed/23227328 http://dx.doi.org/10.1155/2012/608593 |
Ejemplares similares
-
Association of Localized Hypersensitivity and In-Stent Neoatherosclerosis with the Very Late Drug-Eluting Stent Thrombosis
por: Yamaji, Kyohei, et al.
Publicado: (2014) -
Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation
por: Kee, Won Ju, et al.
Publicado: (2011) -
Myocardial bridging is a potential risk factor of very late stent thrombosis of drug eluting stent
por: Jiang, Qixia, et al.
Publicado: (2012) -
Kounis Syndrome Presenting as Very Late Stent Thrombosis in an Everolimus-Eluting Stent Following Wasp Stings
por: Min, Jung Hwa, et al.
Publicado: (2013) -
Clinical use of optical coherence tomography to identify angiographic silent stent thrombosis
por: Steigen, Sonja E., et al.
Publicado: (2014)